-
Je něco špatně v tomto záznamu ?
Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study
S. Matarraz, P. Leoz, A. Yeguas-Bermejo, V. van der Velden, AE. Bras, JI. Sánchez Gallego, Q. Lecrevisse, R. Ayala-Bueno, C. Teodosio, I. Criado, M. González-González, J. Flores-Montero, A. Avendaño, MB. Vidriales, MC. Chillón, T. González, R....
Blood cancer journal.
2023 ;
13 (1) :
132.
[pub] 20230904
Jazyk angličtina Země Spojené státy americké
Typ dokumentu dopisy, práce podpořená grantem
Perzistentní odkaz
https://www.medvik.cz/link/bmc23016288
Online
Plný text
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Freely Accessible Science Journals
od 2011-01-28
Nature Open Access
od 2011-01-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
Springer Nature OA/Free Journals
od 2011-01-01
- MeSH
- akutní myeloidní leukemie * genetika MeSH
- kostní dřeň MeSH
- lidé MeSH
- mutace MeSH
- nukleofosmin * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- dopisy MeSH
- práce podpořená grantem MeSH
CSIC University of Salamanca) Salamanca Spain
Department of Hematology Complejo Asistencial de Ávila Ávila Spain
Department of Hematology Complejo Asistencial de Zamora Zamora Spain
Department of Hematology Complejo Asistencial Universitario de León León Spain
Department of Hematology Complejo Asistencial Universitario de Palencia Palencia Spain
Department of Hematology Hospital Clínico Universitario de Valladolid Valladolid Spain
Department of Hematology Hospital Universitario de Burgos Burgos Spain
Department of Immunology Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands
Department of Immunology Leiden University Medical Center Leiden The Netherlands
Department of Medicine University of Salamanca Salamanca Spain
Dutch Childhood Oncology Group The Hague The Netherlands
FACS Stem Cell Laboratory Kantonsspital Aarau Aarau Switzerland
Hematology Service Hospital Clinic Barcelona Spain
Hematology Service University Hospital of Getafe Madrid Spain
Pathology Service Hospital del Mar Barcelona Spain
Translational and Clinical Research Program Centro de Investigación del Cáncer (IBMCC
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016288
- 003
- CZ-PrNML
- 005
- 20231026110046.0
- 007
- ta
- 008
- 231013s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41408-023-00909-4 $2 doi
- 035 __
- $a (PubMed)37666856
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Matarraz, Sergio $u Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. smats@usal.es $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain. smats@usal.es $1 https://orcid.org/0000000346348005
- 245 10
- $a Baseline immunophenotypic profile of bone marrow leukemia cells in acute myeloid leukemia with nucleophosmin-1 gene mutation: a EuroFlow study / $c S. Matarraz, P. Leoz, A. Yeguas-Bermejo, V. van der Velden, AE. Bras, JI. Sánchez Gallego, Q. Lecrevisse, R. Ayala-Bueno, C. Teodosio, I. Criado, M. González-González, J. Flores-Montero, A. Avendaño, MB. Vidriales, MC. Chillón, T. González, R. García-Sanz, MI. Prieto Conde, N. Villamor, L. Magnano, E. Colado, P. Fernández, E. Sonneveld, J. Philippé, M. Reiterová, JC. Caballero Berrocal, FJ. Diaz-Gálvez, F. Ramos, J. Dávila Valls, R. Manjón Sánchez, J. Solano Tovar, X. Calvo, L. García Alonso, L. Arenillas, S. Alonso, A. Fonseca, C. Quirós Caso, JJM. van Dongen, A. Orfao
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nukleofosmin $7 D000090243
- 650 _2
- $a kostní dřeň $7 D001853
- 650 12
- $a akutní myeloidní leukemie $x genetika $7 D015470
- 650 _2
- $a mutace $7 D009154
- 655 _2
- $a dopisy $7 D016422
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Leoz, Pilar $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain $u Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain $1 https://orcid.org/0000000211395373
- 700 1_
- $a Yeguas-Bermejo, Ana $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain $u Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain
- 700 1_
- $a van der Velden, Vincent $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands $1 https://orcid.org/0000000194573763
- 700 1_
- $a Bras, Anne E $u Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
- 700 1_
- $a Sánchez Gallego, Jose I $u Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain $1 https://orcid.org/0000000179069032
- 700 1_
- $a Lecrevisse, Quentin $u Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain $1 https://orcid.org/0000000187155846
- 700 1_
- $a Ayala-Bueno, Rosa $u Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain
- 700 1_
- $a Teodosio, Cristina $u Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain
- 700 1_
- $a Criado, Ignacio $u Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain
- 700 1_
- $a González-González, María $u Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain
- 700 1_
- $a Flores-Montero, Juan $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain $u Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain $1 https://orcid.org/0000000211194387
- 700 1_
- $a Avendaño, Alejandro $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain $u Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain
- 700 1_
- $a Vidriales, María B $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain $u Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain $1 https://orcid.org/0000000150493673
- 700 1_
- $a Chillón, María C $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain $u Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain
- 700 1_
- $a González, Teresa $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain $u Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain
- 700 1_
- $a García-Sanz, Ramón $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain $u Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain $1 https://orcid.org/0000000341202787
- 700 1_
- $a Prieto Conde, María I $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain $u Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain
- 700 1_
- $a Villamor, Neus $u Hematology Service, Hospital Clinic, Barcelona, Spain
- 700 1_
- $a Magnano, Laura $u Hematology Service, Hospital Clinic, Barcelona, Spain $1 https://orcid.org/0000000269288386
- 700 1_
- $a Colado, Enrique $u Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain
- 700 1_
- $a Fernández, Paula $u FACS/Stem Cell Laboratory, Kantonsspital Aarau, Aarau, Switzerland $1 https://orcid.org/0000000332376283
- 700 1_
- $a Sonneveld, Edwin $u Dutch Childhood Oncology Group, The Hague, The Netherlands
- 700 1_
- $a Philippé, Jan $u Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium
- 700 1_
- $a Reiterová, Michaela $u CLIP-Department of Pediatric Hematology and Oncology, Second Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Caballero Berrocal, Juan C $u Department of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
- 700 1_
- $a Diaz-Gálvez, Francisco J $u Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain
- 700 1_
- $a Ramos, Fernando $u Department of Hematology, Complejo Asistencial Universitario de León, León, Spain
- 700 1_
- $a Dávila Valls, Julio $u Department of Hematology, Complejo Asistencial de Ávila, Ávila, Spain
- 700 1_
- $a Manjón Sánchez, Raquel $u Department of Hematology, Complejo Asistencial de Zamora, Zamora, Spain
- 700 1_
- $a Solano Tovar, Jackeline $u Department of Hematology, Complejo Asistencial Universitario de Palencia, Palencia, Spain
- 700 1_
- $a Calvo, Xavier $u Pathology Service, Hospital del Mar, Barcelona, Spain
- 700 1_
- $a García Alonso, Luis $u Hematology Service, University Hospital of Getafe, Madrid, Spain
- 700 1_
- $a Arenillas, Leonor $u Pathology Service, Hospital del Mar, Barcelona, Spain
- 700 1_
- $a Alonso, Sara $u Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain $1 https://orcid.org/0000000305606362
- 700 1_
- $a Fonseca, Ariana $u Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain
- 700 1_
- $a Quirós Caso, Covadonga $u Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain
- 700 1_
- $a van Dongen, Jacques J M $u Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain $u Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands $1 https://orcid.org/0000000236507087
- 700 1_
- $a Orfao, Alberto $u Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. orfao@usal.es $u Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain. orfao@usal.es $1 https://orcid.org/0000000200077230
- 773 0_
- $w MED00187996 $t Blood cancer journal $x 2044-5385 $g Roč. 13, č. 1 (2023), s. 132
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37666856 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026110040 $b ABA008
- 999 __
- $a ok $b bmc $g 2000042 $s 1202650
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 13 $c 1 $d 132 $e 20230904 $i 2044-5385 $m Blood cancer journal $n Blood Cancer J $x MED00187996
- LZP __
- $a Pubmed-20231013
